May 19, 2020 / 01:10PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Great. Good morning. Thanks, everybody, for joining us this morning for our next presentation in the virtual med tech track here at the UBS Healthcare Conference. I'm Matt Taylor. UBS' U.S. medical supplies and devices analyst. And I'm really pleased to be joined by management from Boston Scientific. We have a few members of the management team on the line today: Susie Lisa from Investor Relations; Lauren Tengler also Director of IR; and we have Jeff Mirviss, who's the EVP and President of the Peripheral Interventions Group, along with Dr. Michael Jaff, who's the VP of Clinical Affairs, Innovation and Technology for the group as well. So this should be a good opportunity to talk both about COVID management, but also focus on the peripheral group, which has really got a lot of exciting product launches coming down the pipe that we'll talk about.
Just one piece of orientation for the call. If you're not familiar with the format yet. This will be about a 40-minute Q&A
Boston Scientific Corp at UBS Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot